[Nalidixic acid (Wintomylon) and bacterial resistance to antibiotics in urinary tract infections].
D001419:Bacteria / Q000187:drug effects; D002701:Chloramphenicol / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D009268:Nalidixic Acid / Q000627:therapeutic use*; D009827:Oleandomycin / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D009268:Nalidixic Acid; D007612:Kanamycin; D002701:Chloramphenicol; D013752:Tetracycline; D009827:Oleandomycin; D013307:Streptomycin